CINV Existing and Pipeline Drugs Market to reach US$ 3.2 billion in 2031, expanding at a CAGR of 5.8%: TMR Report
A significant portion of current research and development efforts, higher federal healthcare funding, and a growing geriatric cancer incidence are some of the drivers propelling the global CINV existing and pipeline drugs market.Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) -- In 2021, the global CINV existing and pipeline drugs market was estimated to be worth US$ 1.9 billion. It is expected to increase at a 5.8% CAGR from 2022 to 2031. The global market for CINV existing
Source: yahoo.com
